KORU Medical Systems, Inc. (KRMD)

NASDAQ | Technology | Medical technology and infusion systems
Free
No email, no account, no signup.
Pulling latest news for KORU Medical Systems, Inc.…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Technology
Sector
Medical technology and infusion systems
Market Cap
$193M
We're already tracking KORU Medical Systems, Inc. — here are the latest events we've registered

Recent News

  • On May 6, 2026, the company reported Q1 2026 revenue of $11.8 million, a 22% increase year-over-year, driven by strong international growth. The company also announced a CEO transition with Adam Kalbermatten set to succeed Linda Tharby by mid-2026.
Want to know how this news affects KORU Medical Systems, Inc.? Order the analysis.
Order analysis – $4.99

What you get

A complete express analysis — not just a signal. Delivered as a webpage in your account.

  • Signal: BUY / HOLD / SELL — with clear reasoning
  • Sentiment score 1–10 based on news, reports, and market data
  • Risk score 1–10 (dilution, jurisdiction, execution)
  • Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
  • Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
  • Upcoming catalysts with dates
  • Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of KORU Medical Systems, Inc. will be delivered in the same format.
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
KORU Medical Systems, Inc. (KRMD)
Fresh analysis on demand
Order analysis – $4.99
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.